Immunotherapy Provide New Hope for Kidney Disease Patients

Immunotherapy research is one of the hottest and controversial topics whether it is in medical, ethical or political fronts. However, the research on Immunotherapy is proceeding fast without stop, and these researches provide new hopes for Kidney Disease.

Generally speaking, there are two types of Immunotherapy based on their origin: adult Immunotherapy(ASCs) and Immunotherapy(ESCs). Both types are important in providing new hope for Kidney Disease.A New Treatment for CKD Patients to Avoid Dialysis and Kidney Transplant: Immunotherapy Shijiazhuang Kidney Disease Hospital

ASCs VS. ESCs

Researchers have conducted studies to see if the Immunotherapy found in the adult body have the same ability and promise as those in embryos. They found that EMCs have the greater potential to treating or curing a wide variety of diseases, while ASCs appear to be less versatile.

ESCs may develop into virtually every type of cells found in the body. However, ASCs may develop into a limited cell types. ESCs can divide indefinitely when they are placed in a culture dish while ASCs may not be so effective, which thereby reduce their ability to form new types of cells.A New Treatment for CKD Patients to Avoid Dialysis and Kidney Transplant: Immunotherapy Shijiazhuang Kidney Disease Hospital

So scientists advocate that both researches on ASCs and ESCs should be continued since they are both offer new hope in the remedy of serious diseases including Kidney Disease.

Immunotherapy Treating Kidney Disease

In 2001, scientists discovered that cells in bone marrows can be turned into tissue, which could help treat kidney damage by some reasons, furthermore, they found out that bone marrow cells were really transformed into kidney tissues.

Immunotherapy from the patients’ own bone marrow have advantages compared with those from other origins. For example, they have much less complications or rejecting reactions when Immunotherapy are transplanted.A New Treatment for CKD Patients to Avoid Dialysis and Kidney Transplant: Immunotherapy Shijiazhuang Kidney Disease Hospital

Advances in Immunotherapy technology and tissue engineering hold great promise for regenerative nephrology. And, studies have demonstrated benefits in treating Pyelonephritis, which is one of the main cause for End Stage Renal Disease(ESRD).

Besides, Immunotherapy technologies applied in animal especially in mice for the Kidney Disease have demonstrated promising future. So we have a sufficient good reason to believe Immunotherapy research can also provide new hopes for kidney disease in human.